{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T10:17:40Z","timestamp":1747736260964,"version":"3.37.3"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R33CA196458"],"award-info":[{"award-number":["1R33CA196458"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.mayocp.2018.06.028","type":"journal-article","created":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T01:25:38Z","timestamp":1546478738000},"page":"27-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Large Chromosomal Rearrangements Yield Biomarkers to Distinguish Low-Risk From Intermediate- and High-Risk Prostate Cancer"],"prefix":"10.1016","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3401-3497","authenticated-orcid":false,"given":"George","family":"Vasmatzis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhad","family":"Kosari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Terra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7619-4951","authenticated-orcid":false,"given":"Irina V.","family":"Kovtun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faye R.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shabnam","family":"Zarei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James B.","family":"Smadbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah H.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios G.","family":"Gaitatzes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terry M.","family":"Therneau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laureano J.","family":"Rangel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan A.","family":"Knudson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Greipp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William R.","family":"Sukov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darlene L.","family":"Knutson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara M.","family":"Kloft-Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Jeffrey","family":"Karnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John C.","family":"Cheville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.mayocp.2018.06.028_bib1","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.eururo.2016.07.017","article-title":"Optimizing active surveillance","volume":"70","author":"Carter","year":"2016","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.mayocp.2018.06.028_bib2","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/1097-0142(20010115)91:2<354::AID-CNCR1009>3.0.CO;2-9","article-title":"Pathologic staging of renal cell carcinoma: significance of tumor classification with the 1997 TNM staging system","volume":"91","author":"Gettman","year":"2001","journal-title":"Cancer"},{"issue":"suppl 4","key":"10.1016\/j.mayocp.2018.06.028_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/bju.13467","article-title":"Prostate cancer grading: recent developments and future directions","volume":"117","author":"Delahunt","year":"2016","journal-title":"BJU Int"},{"issue":"3, pt 1","key":"10.1016\/j.mayocp.2018.06.028_bib4","first-page":"860","article-title":"Pathological features after radical prostatectomy in potential candidates for active monitoring","volume":"178","author":"Griffin","year":"2007","journal-title":"J\u00a0Urol"},{"issue":"5748","key":"10.1016\/j.mayocp.2018.06.028_bib5","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1126\/science.1117679","article-title":"Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer","volume":"310","author":"Tomlins","year":"2005","journal-title":"Science"},{"issue":"22","key":"10.1016\/j.mayocp.2018.06.028_bib6","doi-asserted-by":"crossref","first-page":"8994","DOI":"10.1158\/0008-5472.CAN-10-1358","article-title":"The ability of biomarkers to predict systemic progression in men with high-risk prostate cancer treated surgically is dependent on ERG status","volume":"70","author":"Karnes","year":"2010","journal-title":"Cancer Res"},{"issue":"30","key":"10.1016\/j.mayocp.2018.06.028_bib7","doi-asserted-by":"crossref","first-page":"29087","DOI":"10.18632\/oncotarget.4900","article-title":"Chromosomal catastrophe is a frequent event in clinically insignificant prostate cancer","volume":"6","author":"Kovtun","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.mayocp.2018.06.028_bib8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/modpathol.2015.136","article-title":"Integrated analysis of the genomic instability of PTEN in clinically insignificant and significant prostate cancer","volume":"29","author":"Murphy","year":"2016","journal-title":"Mod Pathol"},{"issue":"11","key":"10.1016\/j.mayocp.2018.06.028_bib9","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/1097-0142(20010601)91:11<2196::AID-CNCR1249>3.0.CO;2-#","volume":"91","author":"Sebo","year":"2001","journal-title":"Cancer"},{"issue":"7153","key":"10.1016\/j.mayocp.2018.06.028_bib10","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nature06024","article-title":"Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer","volume":"448","author":"Tomlins","year":"2007","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.mayocp.2018.06.028_bib11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1593\/neo.07822","article-title":"Role of the TMPRSS2-ERG gene fusion in prostate cancer","volume":"10","author":"Tomlins","year":"2008","journal-title":"Neoplasia"},{"issue":"6","key":"10.1016\/j.mayocp.2018.06.028_bib12","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/ijc.21976","article-title":"Genetic aberrations in prostate cancer by microarray analysis","volume":"119","author":"Saram\u00e4ki","year":"2006","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.mayocp.2018.06.028_bib13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/gcc.20001","article-title":"Evaluation of genetic patterns in different tumor areas of intermediate-grade prostatic adenocarcinomas by high-resolution genomic array analysis","volume":"39","author":"van Dekken","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"10.1016\/j.mayocp.2018.06.028_bib14","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0002-9440(10)63983-1","article-title":"Molecular cytogenetic analysis of prostatic adenocarcinomas from screening studies: early cancers may contain aggressive genetic features","volume":"158","author":"Alers","year":"2001","journal-title":"Am J Pathol"},{"issue":"13","key":"10.1016\/j.mayocp.2018.06.028_bib15","first-page":"3091","article-title":"Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping","volume":"56","author":"Cher","year":"1996","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.mayocp.2018.06.028_bib16","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/modpathol.2013.163","article-title":"MYC amplification and overexpression in primary cutaneous angiosarcoma: a fluorescence in-situ hybridization and immunohistochemical study","volume":"27","author":"Shon","year":"2014","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.mayocp.2018.06.028_bib17","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1200\/JCO.2010.30.2125","article-title":"C-MYC alterations and association with patient outcome in early-stage HER2-positive breast cancer from the North Central Cancer Treatment Group N9831 adjuvant trastuzumab trial","volume":"29","author":"Perez","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"35","key":"10.1016\/j.mayocp.2018.06.028_bib18","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1038\/onc.2011.554","article-title":"Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancer","volume":"31","author":"Liu","year":"2012","journal-title":"Oncogene"},{"issue":"37","key":"10.1016\/j.mayocp.2018.06.028_bib19","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1038\/onc.2011.590","article-title":"Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness","volume":"31","author":"Huang","year":"2012","journal-title":"Oncogene"},{"issue":"7406","key":"10.1016\/j.mayocp.2018.06.028_bib20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature11125","article-title":"The mutational landscape of lethal castration-resistant prostate cancer","volume":"487","author":"Grasso","year":"2012","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.mayocp.2018.06.028_bib21","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1158\/0008-5472.CAN-12-1342","article-title":"CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer","volume":"73","author":"Burkhardt","year":"2013","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.mayocp.2018.06.028_bib22","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/ng.452","article-title":"Multiple loci on 8q24 associated with prostate cancer susceptibility","volume":"41","author":"Al Olama","year":"2009","journal-title":"Nat Genet"},{"issue":"14","key":"10.1016\/j.mayocp.2018.06.028_bib23","first-page":"5271","article-title":"Gene amplifications associated with the development of hormone-resistant prostate cancer","volume":"9","author":"Edwards","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.mayocp.2018.06.028_bib24","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/sj.emboj.7600588","article-title":"Expression of AMAP1, an ArfGAP, provides novel targets to inhibit breast cancer invasive activities","volume":"24","author":"Onodera","year":"2005","journal-title":"EMBO J"},{"issue":"11","key":"10.1016\/j.mayocp.2018.06.028_bib25","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1158\/0008-5472.CAN-07-5237","article-title":"ASAP1, a gene at 8q24, is associated with prostate cancer metastasis","volume":"68","author":"Lin","year":"2008","journal-title":"Cancer Res"},{"issue":"12","key":"10.1016\/j.mayocp.2018.06.028_bib26","doi-asserted-by":"crossref","first-page":"e114104","DOI":"10.1371\/journal.pone.0114104","article-title":"Overexpression of MEOX2 and TWIST1 is associated with H3K27me3 levels and determines lung cancer chemoresistance and prognosis","volume":"9","author":"\u00c1vila-Moreno","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.mayocp.2018.06.028_bib27","doi-asserted-by":"crossref","first-page":"7644","DOI":"10.18632\/oncotarget.3223","article-title":"HDAC9 promotes glioblastoma growth via TAZ-mediated EGFR pathway activation","volume":"6","author":"Yang","year":"2015","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.mayocp.2018.06.028_bib28","first-page":"11818","article-title":"Up-regulation of HDAC9 promotes cell proliferation through suppressing p53 transcription in osteosarcoma","volume":"8","author":"Zhao","year":"2015","journal-title":"Int J Clin Exp Med"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619618305469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619618305469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T15:56:46Z","timestamp":1546531006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619618305469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0025619618305469"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2018.06.028","relation":{},"ISSN":["0025-6196"],"issn-type":[{"type":"print","value":"0025-6196"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Large Chromosomal Rearrangements Yield Biomarkers to Distinguish Low-Risk From Intermediate- and High-Risk Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2018.06.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}